Study of the Effect of Zhuang Medicine Aponeurotic System Triple Therapy on Lumbar Disc Herniation and Alpha-1 Acid Glycoprotein Level

 Objective: To analyze the application effect of Zhuang medicine aponeurotic system triple therapy in the treatment of lumbar disc herniation and its effect on the level of alpha-1 acid glycoprotein (alpha-1 AGP). Methods: 200 patients with lumbar disc herniation were selected and randomly divided into a treatment group and a control group, 100 cases in each group. The control group was given conventional acupuncture, and the treatment group was treated with manipulation + fire needling + cupping. The alpha-1-AGP levels before and after treatment, as well as the lumbar spine function and pain scores before and after treatment, and the adverse reactions occurred during treatment between the two groups were compared. Results: Before treatment, there was no significant difference in alpha-1 AGP levels, lumbar function, and pain scores between the two groups (P > 0.05). After treatment, the lumbar function scores of the two groups were significantly increased, with the treatment group having higher scores than the control group (P < 0.05); the incidence of adverse reactions in the treatment group was 2.00%, which was much lower than the control group (P > 0.05). Conclusion: Appropriate application of Zhuang medicine aponeurotic system triple therapy in the clinical treatment of lumbar disc herniation can promote the improvement of alpha-1 AGP index level, reduce the pain degree of patients, and improve their lumbar spine function. At the same time, Zhuang medicine also has significant advantages in terms of safety, while ensuring the efficacy and safety of the treatment.